Profile for Lithuania Patent: 3100727
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Lithuania Patent: 3100727
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Sep 15, 2030 | Janssen Biotech | ERLEADA | apalutamide |
| ⤷ Start Trial | Mar 27, 2027 | Janssen Biotech | ERLEADA | apalutamide |
| ⤷ Start Trial | Mar 27, 2027 | Janssen Biotech | ERLEADA | apalutamide |
| ⤷ Start Trial | Mar 27, 2027 | Janssen Biotech | ERLEADA | apalutamide |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
